Cue Biopharma, Inc. (CUE) Revenue History
Cue Biopharma, Inc. (CUE) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2018-12-31 | $1.14M |
| 2019-12-31 | $3.46M |
| 2020-12-31 | $3.15M |
| 2021-12-31 | $14.94M |
| 2022-12-31 | $1.25M |
| 2023-12-31 | $5.49M |
| 2024-12-31 | $9.29M |
| 2025-12-31 | $27.47M |
How CUE compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| VYGR | Voyager Therapeutics Inc. | $40.37M |
| EYPT | EyePoint Pharmaceuticals Inc. | $31.37M |
| ALEC | Alector Inc. | $21.05M |
| VERU | Veru Inc. | $16.89M |
| NMTC | NeuroOne Medical Technologies Corporation | $9.10M |
These are five companies in the same sector as CUE with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Cue Biopharma, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("CUE", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | CUE | $23.98 | -2.56% | 0.18M |
| 3 | ||||
| 4 | ||||
| 5 |